Complete heart block associated with regadenoson: a real side effect

J Nucl Cardiol. 2012 Dec;19(6):1236-9. doi: 10.1007/s12350-012-9610-1. Epub 2012 Aug 23.

Authors

Anil Pandit¹, Samuel Unzek Freiman

Affiliation

¹ Division of Cardiovascular Diseases, Mayo Clinic in Arizona, 13400 E Shea Blvd., Scottsdale, AZ 85259, USA. pandit.anil@mayo.edu

PMID: 22915132
DOI: 10.1007/s12350-012-9610-1

No abstract available

Publication types

Case Reports

MeSH terms

Adenosine A2 Receptor Agonists / adverse effects
Aged
Aminophylline / therapeutic use
Bronchodilator Agents / therapeutic use
Female
Heart Block / chemically induced*
Heart Block / drug therapy
Humans
Kidney Failure, Chronic / therapy
Kidney Transplantation
Myocardial Perfusion Imaging* / methods
Preoperative Period*
Purines / administration & dosage
Purines / adverse effects*
Pyrazoles / administration & dosage
Pyrazoles / adverse effects*
Renal Dialysis
Treatment Outcome
Vasodilator Agents / administration & dosage
Vasodilator Agents / adverse effects*

Substances

Adenosine A2 Receptor Agonists
Bronchodilator Agents
Purines
Pyrazoles
Vasodilator Agents
Aminophylline
regadenoson